切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - GTPases - Calcium-Activated Potassium (KCa) Channels - HCV Proteases - Farnesoid X receptors (FXRs)

10 件产品

每页
清除全部
  1. Obeticholic Acid
    B4888 Obeticholic Acid
     2 Citation
    中文名: 奥贝胆酸
    Target: Farnesoid X receptors (FXRs)
    Summary: FXR激动剂
      ≥21.5 mg/mL
      insoluble in H2O
  2. Dequalinium Chloride
    B2191 Dequalinium Chloride
    中文名: 地喹氯铵
    Target: PKC|Calcium-Activated Potassium (KCa) Channels
    Summary: PKC抑制剂
      insoluble in DMSO
      insoluble in H2O
  3. XL335
    B1528 XL335
    Target: Farnesoid X receptors (FXRs)
    Summary: FXR激动剂
      ≥20.4 mg/mL
      insoluble in H2O
  4. Lithocholic Acid
    A8463 Lithocholic Acid
    中文名: 石胆酸
    Target: Farnesoid X receptors (FXRs)|Vitamin D receptors (VDRs)|Pregnane X receptor(PXR)
    Summary: 维生素D受体PXR和FXR的激活剂
      ≥12.95 mg/mL
      insoluble in H2O
  5. Dynasore
    A1605 Dynasore
     4 Citation
    Target: GTPases
    Summary: Dynamin(动力素)GTP酶抑制剂
      ≥16.12 mg/mL
      insoluble in H2O
  6. Daclatasvir (BMS-790052)
    A5618 Daclatasvir (BMS-790052)
    中文名: 达卡他韦
    Target: HCV Proteases
    Summary: HCV NS5A抑制剂
      ≥36.6 mg/mL
      insoluble in H2O
  7. Zonisamide
    A5354 Zonisamide
    中文名: 唑尼沙胺
    Target: Voltage-gated Sodium (NaV) Channels|Voltage-gated Calcium Channels (CaV)|Carbonic Anhydrases|Calcium-Activated Potassium (KCa) Channels
    Summary: 抗惊厥和机械效应的抗癫痫药
      ≥8.35 mg/mL
      insoluble in H2O
  8. TRAM-34
    A1888 TRAM-34
    Target: Calcium-Activated Potassium (KCa) Channels
    Summary: KCa3.1阻断剂
      ≥17.25 mg/mL
      insoluble in H2O
  9. Simeprevir
    A3820 Simeprevir
     1 Citation
    中文名: 西咪匹韦
    Target: HCV Proteases
    Summary: HCV NS3/4A蛋白酶抑制剂
      ≥18.75 mg/mL
      insoluble in H2O
  10. Danoprevir (RG7227)
    A4024 Danoprevir (RG7227)
    中文名: 丹诺瑞韦
    Target: HCV Proteases
    Summary: HCV NS3/4A蛋白酶抑制剂
      ≥32.6 mg/mL
      insoluble in H2O

10 件产品

每页